ArticleInternational journal of chronic obstructive pulmonary disease2025
Association Between C-Reactive Protein to Lymphocyte Ratio and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic significance of the C-reactive protein-to-lymphocyte ratio in patients with cancers.Frontiers in oncology · 2026Pooled it
- C-reactive protein-to-lymphocyte ratio and stroke: associations with prevalence and subsequent mortality in NHANES 1999-2010.Clinical and experimental medicine · 2026Article
- Relationship between high-sensitivity C-reactive protein/lymphocyte ratio and post-thrombolysis short-term outcome in acute ischemic stroke patients.Frontiers in aging neuroscience · 2026Article
- Phenotype-specific association of C-reactive protein-to-lymphocyte ratio with incident proteinuric CKD versus isolated eGFR decline: a real-world retrospective cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The inflammatory response plays a critical role in the progression and prognosis of Chronic Obstructive Pulmonary Disease (COPD). The C-reactive protein to lymphocyte ratio (CLR) has emerged as a potential novel biomarker of systemic inflammation. Nevertheless, the association between CLR and COPD remains unclear. The objective of this study was to explore the possible connection between CLR and COPD. Methods: We conducted a retrospective study on 22,581 participants from the NHANES dataset (1999-2010). To evaluate the relationship between CLR and COPD, logistic regression analysis, restricted cubic spline analysis, and threshold effect analysis were utilized. Furthermore, subgroup and sensitivity analyses were conducted to assess the robustness of the identified association. Results: Multivariate logistic regression models indicated that the ln-transformed CLR was significantly associated with an increased risk of COPD (OR: 1.14, 95% CI: 1.04-1.25; P = 0.005). Compared to participants classified with the first tertile of ln-transformed CLR (T1), the risks of COPD for those in T2 and T3 were 1.03 and 1.33 times higher, respectively. An evident upward trend was noted with an increase in the ln-transformed CLR (P for trend =0.032). Furthermore, an inverse L-shaped association was identified between the ln-transformed CLR and the risk of COPD. The robustness and consistency of these findings were further confirmed by subgroup and sensitivity analyses. Conclusion: Increased CLR correlated with a heightened risk of developing COPD, exhibiting nonlinear patterns and threshold effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.